Press Releases Trinity Biotech plc

Stocks

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 16/07/2026 BST			5-day change	1st Jan Change
0.3707 ^USD	+3.00%		-5.26%	-53.14%

07-15	European Equities Traded in the US as American Depositary Receipts Advance Wednesday	MT
07-08	European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading	MT

Press Releases

07-02	New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring	AQ
06-30	Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling	AQ
06-29	Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville	AQ
06-23	Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market	AQ
06-16	Trinity Biotech : Financial Results for Quarter 1, 2026	PU
06-16	Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results	AQ
05-01	Trinity Biotech : Financial Results for Quarter 4, 2025 and FY2025	PU
05-01	Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations	AQ
03-24	Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test	AQ
03-18	Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren’s Syndrome	AQ
03-12	Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System	AQ
03-11	Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program	AQ
03-10	Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform	AQ
03-10	Trinity Biotech Provides Business and Trading Update	AQ
02-25	Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives	AQ
02-20	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares	AQ
02-13	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement	AQ
02-10	Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation	AQ
02-10	Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210™ HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026	AQ
12-23	Trinity Biotech : Financial Results for Quarter 3, 2025	PU
12-23	Trinity Biotech : Financial Results for Quarter 2, 2025	PU
12-23	Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives	AQ
12-23	Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests	AQ
12-15	Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances	AQ
11-18	Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation	AQ